Search

Displaying results 1 - 10 of 7399 in total
  1. Drug

    TO-901317

    go.drugbank.com/drugs/DB07080
    Experimental

    TO-901317 is an LXRalpha and LXRbeta agonist.

  2. Drug

    NZ-1002

    go.drugbank.com/drugs/DB17688
    Experimental

    Synonyms: NZ 1002, NZ-1002
  3. Drug

    Nz-(Dicarboxymethyl)Lysine

    go.drugbank.com/drugs/DB01815
    Experimental

    Synonyms: Nz-(Dicarboxymethyl)Lysine
  4. Drug

    Schizochytrium DHA oil

    go.drugbank.com/drugs/DB11069
    Approved

    Synonyms: DHA from algal (schizochytrium) oil
  5. Drug

    Lysine Nz-Carboxylic Acid

    go.drugbank.com/drugs/DB03801
    Experimental

    Synonyms: Lysine Nz-Carboxylic Acid
  6. Drug

    Nz-(1-Carboxyethyl)-Lysine

    go.drugbank.com/drugs/DB02370
    Experimental

    Synonyms: Nz-(1-Carboxyethyl)-Lysine
  7. Drug

    Haemophilus influenzae b polysaccharide-tetanus conjugate

    go.drugbank.com/drugs/DB15876
    ApprovedInvestigational

    Synonyms: Haemophilus influenzae type b polysaccharide conjugated to tetanus protein, Haemophilus influenzae type b polysaccharide conjugated to the tetanus protein
  8. Drug

    Linvoseltamab

    go.drugbank.com/drugs/DB17447
    ApprovedInvestigational

    By binding to both targets simultaneously, linvoseltamab redirects T cells toward myeloma cells, forming an immunological synapse that activates T-cell–mediated cytotoxicity. … cells with CD3-expressing T cells.

    Categories: Bispecific B Cell Maturation Antigen-directed CD3 T Cell EngagerSynonyms: human IgG4-based anti-CD3 x anti-BCMA bispecific monoclonal antibody that binds to CD3 and BCMA
  9. Drug

    Brentuximab vedotin

    go.drugbank.com/drugs/DB08870
    ApprovedInvestigational

    Importantly, bleomycin - a highly toxic agent - was completely removed from the regimen. This demonstrates meaningful progress in treatment for patients affected by this disease.[L1739] … [L1737] Adcetris has also been previously approved by the FDA to treat Hodgkin's lymphoma after relapse, Hodgkin's lymphoma after stem cell transplantation when a patient has a high risk of relapse

    Synonyms: Moab, chimeric, SGN-30, to CD30 antigenProducts: ADCETRIS 50 MG IV INFÜZYONLUK ÇÖZELTI KONSANTRESI IÇIN TOZ IÇEREN FLAKON ,FLAKON, 1 ADET
  10. Drug

    Loncastuximab tesirine

    go.drugbank.com/drugs/DB16222
    ApprovedInvestigational

    [L45206] This therapy was developed by ADC Therapeutics and its accelerated approval for relapsed or refractory B-cell lymphoma is based on promising results from the LOTIS-2 clinical trial. … [A234439] Prognosis is poor and more effective therapies are needed to treat relapsed/refractory cases and improve survival.

    Synonyms: Humanized monoclonal immunoglobulin G1 antibody directed against human CD19 conjugated to SG3199 through A protease cleavable valine-alanine linker